We surveyed 400 psychiatrists to assess depressive relapse during ongoing selective serotonin reuptake inhibitor (SSRI) treatment and the common strategies to regain remission. Among 119 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback